FeesSafety
Pluang+

CZ denies manipulating Bitcoin price, says crypto market far from saturated.

Market News
25 Sep 2026
Tokenpost
View Source
Neutral
CZ denies manipulating Bitcoin price, says crypto market far from saturated.

CZ, a prominent figure in the cryptocurrency space, denied claims that he manipulates Bitcoin's price. He described the cryptocurrency market, valued at around $3 trillion, as far from saturated, implying there is still significant room for growth and investment. This statement comes amid ongoing discussions about market influence and the potential for further expansion in the crypto sector.

CZ's comments on Bitcoin price and crypto market saturation provide context for readers following cryptocurrency trends. For readers following cryptocurrency, here is Pluang's market snapshot as of Sep 26, 2026 00:21 WIB: out of 50 major cryptocurrencies, 33 rose and 16 fell today. Among notable movers, BAL (Balancer) rose 11.14% to Rp16.297, AXS (Axie Infinity) increased 10.09% to Rp21.165, and EOS (EOS.IO) gained 8.13% to Rp12.649.

More News

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix reports promising Phase 1 results for JNJ-1900 in advanced melanoma resistant to anti-PD-1 therapies

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3), used with radiotherapy and immune checkpoint inhibitors, in 24 heavily pretreated advanced melanoma patients resistant to anti-PD-1 therapies. The treatment showed a 41.7% obj...

Company Fundamentals
Bullish
15 minutes ago
Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte launch trial combining petosemtamab and INCB161734 for KRAS G12D metastatic colorectal cancer.

Genmab and Incyte announced a Phase 1/2 clinical trial to test a combination of petosemtamab, INCB161734, and standard chemotherapy as a first-line treatment for metastatic colorectal cancer with the KRAS G12D mutation. This mutation is common and li...

Company Fundamentals
Bullish
15 minutes ago
AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker launches guide for Business Class flights from the US to 15 global destinations.

AirTripMaker has introduced a comprehensive Business Class Flight Routes Guide to help travelers from the US explore premium flight options to 15 major international destinations across Asia, Europe, Africa, and Australia. The guide covers airlines, ...

Others
Neutral
2 hours ago
Nanobiotix reports promising Phase 1 results for JNJ-1900 in resistant melanoma with 41.7% response rate

Nanobiotix reports promising Phase 1 results for JNJ-1900 in resistant melanoma with 41.7% response rate

Nanobiotix announced positive Phase 1 trial results for JNJ-1900 (NBTXR3) combined with immune checkpoint inhibitors in 24 patients with advanced primary cutaneous melanoma resistant to anti-PD-1 therapy. The treatment showed a 41.7% overall response...

Company Fundamentals
Bullish
4 hours ago
NEAR Protocol to hold Q3 Backers Summit on Oct 28 covering tokenomics, AI, and House of Stake proposal.

NEAR Protocol to hold Q3 Backers Summit on Oct 28 covering tokenomics, AI, and House of Stake proposal.

NEAR Protocol announced a Q3 Backers Summit scheduled for October 28. The event will focus on discussions about its House of Stake issuance proposal, updates on NEAR AI, and integration plans. Tokenomics and AI are key topics, with special guests exp...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App